电子健康记录干预与老年人处方精简:一项随机临床试验
这项3组平行随机临床试验将201名基层医生整群随机分为常规照护组、预承诺干预组和助推干预组,评估电子健康记录工具对老年人潜在不适当药物处方精简的影响。结果显示,预承诺组处方精简率36.8%,助推组34.3%,常规照护组26.8%;与常规照护相比,预承诺组处方精简可能性增加40%(RR 1.40;95%CI 1.14-1.73),助推组增加26%(RR 1.26;95%CI 1.01-1.57)。作者认为结果支持使用基于行为科学原理设计的电子健康记录工具来提高老年人潜在不适当药物的处方精简率。
要点
- 预承诺组处方精简率36.8%,高于常规照护组26.8%(RR 1.40;95%CI 1.14-1.73)。
- 助推组处方精简率34.3%,高于常规照护组26.8%(RR 1.26;95%CI 1.01-1.57)。
- 未报告严重不良事件;预承诺组死亡率1.4%,助推组3.9%,常规照护组1.8%。
核心结论
- 作者认为结果支持使用基于行为科学原理设计的电子健康记录工具来显著提高老年人潜在不适当药物的处方精简率。
研究设计与样本
- 这项3组平行随机临床试验于2022年11月将马萨诸塞州一家学术中心的201名基层医生整群随机分组,随访于2024年3月15日结束。
- 干预对象为随机分组基层医生的患者,年龄65岁及以上,在2022年11月10日至2024年3月15日期间有基层医生就诊,且过去180天内被处方至少90片苯二氮䓬类、非苯二氮䓬类镇静催眠药或至少2种抗胆碱能药物。
- 基层医生被随机分为常规照护组(无干预)或两种序贯电子健康记录干预之一:预承诺干预和助推干预。
- 预承诺干预在患者首次就诊时向医生发送电子健康记录消息,请其启动处方精简讨论,并在患者第二次就诊时发送第二封提醒消息鼓励处方精简。
- 助推干预在患者首次就诊时向基层医生发送鼓励处方精简的通知,并在4周后发送收件箱提醒。
主要发现
- 1146名参与者平均年龄73.6岁(SD 6.4),女性占69.7%,平均随访289.9天。
- 373名(32.5%)至少精简1种药物:预承诺组145名(36.8%),助推组122名(34.3%),常规照护组106名(26.8%)。
- 与常规照护相比,预承诺组处方精简可能性增加40%(RR 1.40;95%CI 1.14-1.73;绝对差异10.4%)。
- 与常规照护相比,助推组处方精简可能性增加26%(RR 1.26;95%CI 1.01-1.57;绝对差异6.5%)。
- 通过不良事件报告系统未报告严重不良事件;基于人工病历审查的死亡率预承诺组为1.4%,助推组为3.9%,常规照护组为1.8%。
临床怎么用
- 作者认为结果支持使用基于行为科学原理设计的电子健康记录工具来显著提高老年人潜在不适当药物的处方精简率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Potentially inappropriate medications are commonly overprescribed to older adults. Although electronic health record (EHR)-based tools can increase use of evidence-based medications, their ability to reduce prescription of potentially inappropriate medications remains unclear. OBJECTIVE: To test the effects of 2 EHR interventions, designed using behavioral science techniques, on the deprescribing of potentially inappropriate medications compared with usual care in older patients. DESIGN, SETTING, AND PARTICIPANTS: In this 3-group parallel randomized clinical trial, 201 primary care physicians (PCPs) in an academic center in Massachusetts were cluster-randomized in November 2022. Follow-up ended March 15, 2024. The intervention focused on patients of randomized PCPs who were 65 years or older, had a PCP visit between November 10, 2022, and March 15, 2024, and were prescribed at least 90 pills of benzodiazepines, nonbenzodiazepine sedative hypnotics, or at least 2 anticholinergic medications in the past 180 days. INTERVENTIONS: PCPs were randomized to usual care (no intervention) or to 1 of 2 sequential EHR interventions: a precommitment intervention, in which an EHR message was sent to the physician during the first patient visit asking the PCP to initiate deprescribing discussions with a second reminder EHR message at the patient's second visit encouraging deprescribing; and a boostering intervention, in which PCPs received a notification encouraging deprescribing at the first patient visit and an in-basket reminder 4 weeks later. MAIN OUTCOMES AND MEASURES: The primary outcome was deprescribing at least 1 medication on or after the first patient visit though the end of follow-up. Deprescribing was defined as physician-directed discontinuation or medication tapering assessed at the patient level using EHR data. Generalized estimating equations with a log link and binary-distributed errors were used for analyses, adjusting for clustering and multiple testing using Holm-Bonferroni corrections. RESULTS: Of 1146 participants (mean age, 73.6 years [SD, 6.4]; 69.7% female, mean follow-up, 289.9 days), 373 (32.5%) had at least 1 medication deprescribed: 145 (36.8%) in the precommitment group, 122 (34.3%) in the boostering group, and 106 (26.8%) in usual care. Compared with usual care, deprescribing was 40% more likely (relative risk [RR], 1.40; 95% CI, 1.14-1.73; absolute difference, 10.4%) in the precommitment group and 26% more likely (RR, 1.26; 95% CI, 1.01-1.57; absolute difference, 6.5%) in the boostering group. No serious adverse events were reported through the adverse event reporting system. Death rates based on manual chart review were 1.4% in the precommitment group, 3.9% in the boostering group, and 1.8% in the usual care group. CONCLUSIONS AND RELEVANCE: These results support use of EHR tools designed using behavioral science principles to significantly increase rates of deprescribing potentially inappropriate medications used by older adults. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT005538065.
引用
- Lauffenburger JC, Sung M, Glynn RJ, et al. Electronic Health Record Intervention and Deprescribing for Older Adults: A Randomized Clinical Trial. JAMA. 2026. PMID: 41609788. doi:10.1001/jama.2025.26967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。